Literature DB >> 23049429

Myelophthisis as first manifestation of failure of chemotherapy in breast cancer.

Leonardo Rodrigues de Oliveira1, Thaís Camargos Ferreira, Antônio Carlos Oliveira de Meneses.   

Abstract

Entities:  

Year:  2012        PMID: 23049429      PMCID: PMC3459620          DOI: 10.5581/1516-8484.20120059

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN: 1516-8484


× No keyword cloud information.
Myelophthisis is a form of bone marrow failure due to the substitution of hematopoietic tissue and its stroma by abnormal tissue(. We report a case of a 38-year-old woman under investigation for bicytopenia during maintenance chemotherapy (tamoxifen) for breast cancer (diagnosed 3 years previously). Her physical examination was unremarkable except for pallor. There was no hepatosplenomegaly, lymphadenopathy or breast lesions. Laboratory tests showed normochromic and normocytic anemia (Hb 9.1 g/dL) and thrombocytopenia (117 x 109/L). A peripheral blood smear showed a typical leukoerythroblastic picture. Bone marrow aspiration (with resistance) and biopsy revealed extensive infiltration by breast ductal carcinoma.
  2 in total

1.  Myelophthisis in breast cancer.

Authors:  Guido D'Angelo; Anna Maria Hotz
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

2.  Clinical spectrum of myelophthisis in cancer patients.

Authors:  Stephen N Makoni; Damian A Laber
Journal:  Am J Hematol       Date:  2004-05       Impact factor: 10.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.